North Dakota 2025 2025-2026 Regular Session

North Dakota House Bill HB1473 Introduced / Bill

Filed 01/17/2025

                    25.1047.01000
Sixty-ninth
Legislative Assembly
of North Dakota
Introduced by
Representatives Nelson, Mitskog, Murphy, Bahl, O'Brien
Senators Axtman, Dever, Lee
A BILL for an Act to create and enact a new subsection to section 43-15.3-08 of the North 
Dakota Century Code, relating to prohibited acts of drug manufacturers; and to provide a 
penalty.
BE IT ENACTED BY THE LEGISLATIVE ASSEMBLY OF NORTH DAKOTA:
SECTION 1. A new subsection to section 43-15.3-08 of the North Dakota Century Code is 
created and enacted as follows:
a.For purposes of this subsection:
(1)"Contract pharmacy" means a pharmacy that has a contract with a covered 
entity to receive and dispense drugs to the covered entity's patients on its 
behalf.
(2)"Covered entity" means an entity participating or authorized to participate in 
a federal drug discount program under 42 U.S.C. 256b.
(3)"Drug" means a drug purchased under reduced pricing under section 340B 
of the federal Public Health Service Act [42 U.S.C. 201 et seq.] by a covered 
entity.
b.Except as otherwise provided under section 43-15.3-09, it is a class   B  
misdemeanor for a manufacturer, an agent or affiliate of that manufacturer, virtual 
manufacturer, or third-party logistics provider of a manufacturer's drugs, to:
(1)Directly or indirectly deny, restrict, prohibit, or otherwise interfere with the 
acquisition of a drug by a contract pharmacy on behalf of a covered entity 
unless receipt of the drug is prohibited by federal law.
(2)Prohibit a contract pharmacy from dispensing a drug by denying access to 
the drug.
Page No. 1	25.1047.01000
 HOUSE BILL NO. 1473
    
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23 Sixty-ninth
Legislative Assembly
(3)Require a covered entity or contract pharmacy to submit any claims, 
encounter, or utilization data as a condition for acquiring or receiving a drug, 
unless the claims, encounter, or utilization data sharing is required by 
federal law.
(4)Interfere with the ability of a covered entity or contract pharmacy to 
dispense a drug to an eligible patient of the covered entity.
(5)Offer or otherwise make available a drug in the form of a rebate, unless in 
the form of a discount at the time of sale and authorized under federal law.
c.This subsection does not apply to the limited distribution of a drug as required 
under 21 U.S.C. 355-1.
Page No. 2	25.1047.01000
1
2
3
4
5
6
7
8
9
10